By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies will partner with EdgeBio and Virginia Commonwealth University in a project that will study how gene regulation and epigenetic markers may be involved in the development of schizophrenia.

The research will involve using Life Technologies' SOLiD System and MethylMiner methylated DNA enrichment kit to conduct genome-wide sequencing and methylation studies of 1,500 individuals, the company said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.